Which statement about acrolein is true in the context of chemotherapy-related bladder toxicity?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which statement about acrolein is true in the context of chemotherapy-related bladder toxicity?

Explanation:
In this context, the harmful factor is acrolein, a metabolite produced when cyclophosphamide and ifosfamide are activated. It is excreted in the urine at high concentrations and irritates the bladder lining, leading to urothelial toxicity such as hemorrhagic cystitis. This explains why protective strategies like Mesna are used to bind acrolein in the urine and why adequate hydration helps reduce risk. Acrolein is not a protective agent, not a benzene derivative, and not an antiemetic.

In this context, the harmful factor is acrolein, a metabolite produced when cyclophosphamide and ifosfamide are activated. It is excreted in the urine at high concentrations and irritates the bladder lining, leading to urothelial toxicity such as hemorrhagic cystitis. This explains why protective strategies like Mesna are used to bind acrolein in the urine and why adequate hydration helps reduce risk. Acrolein is not a protective agent, not a benzene derivative, and not an antiemetic.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy